ClinicalResearch IO

Clinical Research IO (CRIO) offers a range of clinical trial software, including a 1) clinical trial management system to manage patient recruitment, visits, and finances, 2) e-source platform to manage the collection and storage of patient data such as lab reports, examination notes, and self-reported surveys, and 3) e-regulatory platform to manage documentation of regulatory required documents and e-signatures. 

These tools allow researchers to enter and review data electronically, along with enabling patients to monitor and provide consent through the system. Additionally, the system can organize workflow tasks such as payments and reimbursements, manage patient recruitment, and schedule patient visits. Furthermore, the system is compliant with industry standards including HIPAA, GDPR, FDA 21 CFR Part 11, and GCP.

Key customers and partnerships

As of September 2022, the Company’s system has been adopted by over 2,000 clinical research sites, with over 250,000 patients onboarded across 18 geographies. This growth was enabled by CRIO being the first company to achieve mass commercialization of an electronic sourcing system for clinical trials (initially launched in September 2016). The company’s customer base includes Regeneris Medical, Optimed Research, and Medex Healthcare.

Funding and financials

The company raised USD 9 million in January 2022 in Series B funding led by Abbhi Capital, with the proceeds to be used for new strategic partnerships, platform development, and expansion of customer offerings.